|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.980
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.881
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.877
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.839
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.838
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.739
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.697
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.683
|
Mouse |
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.672
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.667
|
|
|
|
response to fluid shear stress
|
GO:0034405 |
7 |
0.659
|
Mouse |
|
|
rhythmic process
|
GO:0048511 |
174 |
0.655
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.652
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.646
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.634
|
|
|
|
cerebellar granule cell precursor tangential migration
|
GO:0021935 |
1 |
0.623
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.619
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.592
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.584
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.575
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.566
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.558
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.549
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.542
|
Mouse |
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.536
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.526
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.517
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.511
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.510
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.505
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.504
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.500
|
Mouse |
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.493
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.487
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.486
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.485
|
|
|
|
circadian behavior
|
GO:0048512 |
13 |
0.479
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.471
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.463
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.460
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.460
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.459
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.457
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.455
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.440
|
Mouse |
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.437
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.434
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.425
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.423
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.414
|
Mouse |
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.410
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.408
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.403
|
|
|
|
cellular response to fluid shear stress
|
GO:0071498 |
4 |
0.402
|
Mouse |
|
|
palate development
|
GO:0060021 |
76 |
0.402
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.391
|
Mouse |
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.386
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.384
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.384
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.382
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.382
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.381
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.380
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.373
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.373
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.368
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.366
|
|
|
|
dendritic spine development
|
GO:0060996 |
30 |
0.362
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.361
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.356
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.356
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.355
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.349
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.345
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.344
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.337
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.336
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.335
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.332
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.332
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.325
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.324
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.322
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.318
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.317
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.316
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.314
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.312
|
|
|
|
positive regulation of protein binding
|
GO:0032092 |
29 |
0.311
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.310
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.309
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.306
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.306
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.304
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.303
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.301
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.299
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.289
|
Mouse |
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.286
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.284
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.284
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.281
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.277
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.277
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.276
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.270
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.269
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.268
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.265
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.262
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.261
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.255
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.252
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.252
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.249
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
21 |
0.245
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.244
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.244
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.240
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.235
|
Worm |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.233
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.232
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.228
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.225
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.223
|
|
|
|
positive regulation of alkaline phosphatase activity
|
GO:0010694 |
3 |
0.220
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.219
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.218
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.218
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.218
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.217
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.214
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.212
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.212
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.209
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.207
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.206
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.205
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.205
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.204
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.203
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.203
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.202
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.201
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.201
|
Mouse |
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.201
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.200
|
Mouse |
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.200
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.200
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.199
|
Mouse |
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.199
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.197
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.195
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.193
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.193
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.191
|
Mouse |
|
|
angiogenesis
|
GO:0001525 |
201 |
0.190
|
Human |
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.190
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.187
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.186
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.186
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.185
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.185
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.185
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.184
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.183
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.179
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.178
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.178
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.178
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.175
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.175
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.175
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.174
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.173
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.173
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.172
|
|
|
|
germinal center formation
|
GO:0002467 |
16 |
0.171
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.169
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.168
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.167
|
Mouse |
|
|
heart formation
|
GO:0060914 |
16 |
0.167
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.167
|
Human Mouse |
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.167
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.166
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.166
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.165
|
Mouse |
|
|
chromatin organization
|
GO:0006325 |
206 |
0.164
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.164
|
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
0.162
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.161
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.161
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.161
|
Human |
|
|
cytokine production
|
GO:0001816 |
319 |
0.161
|
Human |
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.161
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.160
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.160
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.159
|
|
|
|
cd4 positive cd25 positive alpha beta regulatory t cell differentiation
|
GO:0002361 |
4 |
0.159
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.158
|
|
|
|
definitive erythrocyte differentiation
|
GO:0060318 |
7 |
0.157
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.156
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.155
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.153
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.152
|
Human |
|
|
kidney development
|
GO:0001822 |
213 |
0.152
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.149
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.149
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.149
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.148
|
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.148
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.145
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.145
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.144
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.143
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.141
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.140
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.140
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.139
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.138
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.138
|
Mouse |
|
|
regulation of dendritic spine development
|
GO:0060998 |
22 |
0.137
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.136
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.135
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.135
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.134
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.133
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.133
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.133
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.131
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.131
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.131
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.131
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.130
|
Mouse |
|
|
b cell homeostasis
|
GO:0001782 |
34 |
0.130
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.128
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.127
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.127
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.127
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.126
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.126
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.126
|
|
|
|
cellular response to salt stress
|
GO:0071472 |
1 |
0.124
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.123
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.122
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.122
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.122
|
Mouse |
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.121
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.121
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.121
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.121
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.120
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.120
|
Mouse |
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.118
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.116
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.116
|
Mouse |
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.116
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.115
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.115
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.114
|
|
|
|
nephron tubule epithelial cell differentiation
|
GO:0072160 |
11 |
0.114
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.114
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.113
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.112
|
Mouse |
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.111
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.111
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.111
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.109
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.109
|
Mouse |
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.107
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.106
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.105
|
|
|
|
regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072364 |
7 |
0.105
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.105
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.105
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.104
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.103
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.103
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.103
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.102
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.102
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.102
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.101
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.101
|
|
|
|
memory
|
GO:0007613 |
58 |
0.101
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.101
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.100
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.100
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.099
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.099
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.098
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.098
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.096
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.095
|
Mouse |
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.094
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.094
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.094
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.094
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.094
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.094
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.094
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.093
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.093
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.092
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.092
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.091
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.091
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.091
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.091
|
Mouse |
|
|
axonogenesis
|
GO:0007409 |
274 |
0.091
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.090
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.090
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.090
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.090
|
|
|
|
glomerulus morphogenesis
|
GO:0072102 |
10 |
0.090
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.089
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.089
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.089
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.088
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.088
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.088
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.087
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.087
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.087
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.087
|
|
|
|
vagus nerve morphogenesis
|
GO:0021644 |
2 |
0.086
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.086
|
|
|
|
glossopharyngeal nerve morphogenesis
|
GO:0021615 |
4 |
0.086
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.086
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.086
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.085
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.085
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.085
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.084
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
4 |
0.084
|
|
|
|
heart field specification
|
GO:0003128 |
6 |
0.084
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.084
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.084
|
|
|
|
cellular response to osmotic stress
|
GO:0071470 |
7 |
0.084
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.084
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.082
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.081
|
Mouse |
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.081
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.081
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.080
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.080
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.080
|
|
|
|
response to symbiont
|
GO:0009608 |
2 |
0.080
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.080
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.080
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.079
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.079
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.079
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.079
|
|
|
|
b 1 b cell homeostasis
|
GO:0001922 |
4 |
0.079
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.078
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.078
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.078
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.077
|
|
|
|
rhythmic behavior
|
GO:0007622 |
15 |
0.077
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.077
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.077
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.077
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.076
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.075
|
Human |
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.075
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.075
|
|
|
|
chemorepulsion of branchiomotor axon
|
GO:0021793 |
1 |
0.075
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.075
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.075
|
|
|
|
positive regulation of mesoderm development
|
GO:2000382 |
2 |
0.074
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.074
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.074
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.073
|
|
|
|
positive regulation of protein homodimerization activity
|
GO:0090073 |
1 |
0.073
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.073
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.072
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.072
|
Mouse |
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.072
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.072
|
Mouse |
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.071
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.071
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.071
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.070
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.069
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.068
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.068
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.068
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.068
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.068
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.068
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.066
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.066
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.066
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.065
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.065
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.065
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.065
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.065
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.064
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.064
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.064
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.064
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.063
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.063
|
Human Mouse |
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.063
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.063
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.063
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.063
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.063
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.062
|
Human |
|
|
closure of optic fissure
|
GO:0061386 |
2 |
0.062
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.061
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.061
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.061
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.061
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.060
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.060
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.059
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.059
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.059
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.059
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.059
|
Human |
|
|
protein targeting
|
GO:0006605 |
143 |
0.058
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.058
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.058
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.057
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.057
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.057
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.057
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.057
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.057
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.057
|
|
|
|
negative regulation of lyase activity
|
GO:0051350 |
1 |
0.057
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.056
|
|
|
|
rhombomere formation
|
GO:0021594 |
1 |
0.056
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
30 |
0.056
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.056
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.056
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.055
|
Human |
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.055
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.055
|
|
|
|
regulation of protein homodimerization activity
|
GO:0043496 |
4 |
0.054
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.054
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.054
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.053
|
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.053
|
|
|
|
regulation of mammary gland epithelial cell proliferation
|
GO:0033599 |
12 |
0.053
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.053
|
|
|
|
cardiac chamber formation
|
GO:0003207 |
10 |
0.052
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.052
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.052
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.052
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.052
|
Human |
|
|
melanocyte differentiation
|
GO:0030318 |
25 |
0.052
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.052
|
Mouse |
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.052
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.052
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.051
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.051
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.051
|
Mouse |
|
|
protein import
|
GO:0017038 |
101 |
0.051
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.051
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.051
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.050
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.050
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.050
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.050
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.050
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.050
|
|
|
|
growth involved in heart morphogenesis
|
GO:0003241 |
4 |
0.050
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.050
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.049
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.049
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.049
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.049
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.049
|
|
|
|
negative regulation of lymphocyte differentiation
|
GO:0045620 |
32 |
0.049
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.049
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.049
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.049
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.048
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001267 |
4 |
0.048
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.048
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.048
|
|
|
|
positive regulation of cardiac muscle tissue development
|
GO:0055025 |
19 |
0.048
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.048
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.048
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.048
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.048
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.047
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.047
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.047
|
|
|
|
positive regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014718 |
2 |
0.047
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.047
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.047
|
|
